For once, let us talk about business!

For the second year in a row, our Managing Director Cesar Carnicer was interviewed by Joseph Harvey (Animal Pharm), business analyst for IHS Markit.

For sure, in these times of pandemic, we all need to read, hear and talk about things that are going well and bring a little positivity to our daily lives. Although we are rather discreet on the subject, for once we are going to talk about Syva from a more ‘business’ angle.

As this economic analyst’s evocatively titled article points out: ‘Syva’s investment in burgeoning vaccine business undeterred by pandemic’, Syva has remained solid despite the sanitary threat and has been well advised to continue developing its vaccine production activities, which now account for a third of its turnover and which reached a decisive turning point in 2019 with the launch of its multi-strain vaccine against blue tongue disease.

If we had to give some achievements of Syva’s activity in 2020, it is

  • A growing turnover;
  • A storage capacity that has almost doubled;
  • A storage capacity linked to the cold chain dedicated to vaccines that has tripled;
  • The establishment of a new subsidiary in Turkey which opens up new horizons;
  • The perspective of launching new vaccines that will strengthen its own product portfolio with high focus on quality.

These are all reasons and opportunities to renew its commitment to its customers by keeping its focus on its mission to offer ‘meaningful solutions for animal health’.

More details in the interview with César Carnicer, CEO of Syva, by Joseph Harvey (Animal Pharm) for IHS Markit: Syvas_investment_in_burgeoning_vaccine_business_undeterred_by_pandemic-2

For more information on IHS Markit: https://ihsmarkit.com/company/index.html

For more information on Syva: www.syva.es/en

You may also be interested in

2 September, 2021

A step forward in the fight against swine erysipelas

For more than 60 years, Syva has been working with veterinarians and pig farmers in the fight against swine erysipelas. Epidemiological studies show that 30-50% of apparently healthy pigs carry Erysipelothrix rhusiopathiae1 bacteria. When uncontrolled, swine erysipelas can affect all stages of pig production, both in white and Iberian pigs, and cause a significant economic impact. The most frequent losses are...

Read more

2 August, 2021

It’s time for us to take a break

We are in summer holidays and, as every year, we invite our colleagues to disconnect and take some time off with their families, away from daily worries.

Read more

29 April, 2021

We are sponsoring the OVIFOTO 2021 Woman Prize!

By sponsoring the Women's Prize, we are highlighting our support for women who participate in the development of the sheep and goat sector, both in the managementof the flocks and in the production and transformation of wool and milk ...

Read more